NASDAQ:AIMD Ainos (AIMD) Stock Price, News & Analysis $1.45 -0.03 (-2.03%) Closing price 04:00 PM EasternExtended Trading$1.44 -0.01 (-0.76%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Ainos Stock (NASDAQ:AIMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ainos alerts:Sign Up Key Stats Today's Range$1.40▼$1.4850-Day Range$1.31▼$2.0452-Week Range$1.26▼$4.44Volume15,461 shsAverage Volume216,824 shsMarket Capitalization$10.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Ainos, Inc. (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations. The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format. AI‐401 is engineered to target airway inflammation in conditions such as cystic fibrosis and other chronic respiratory diseases. In preclinical studies, the formulation demonstrated favorable pulmonary deposition and sustained release, and it has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of cystic fibrosis. In addition to AI‐401, Ainos is exploring the application of its dry powder inhalation technology for other anti‐inflammatory and anti‐infective agents, with the goal of expanding its pipeline into multiple respiratory indications. The company collaborates with contract development and manufacturing organizations (CDMOs) to advance product candidates through formulation optimization, toxicology assessments and early clinical trials. Founded in the United States, Ainos is headquartered in Philadelphia and serves patients and healthcare providers primarily in North America and Europe. The company’s management team comprises executives with extensive experience in respiratory drug development, regulatory affairs and commercial strategy. Ainos aims to leverage its inhalation platform to bring novel pulmonary therapies to market and address unmet medical needs in chronic lung disease.AI Generated. May Contain Errors. Read More Ainos Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreAIMD MarketRank™: Ainos scored higher than 9% of companies evaluated by MarketBeat, and ranked 563rd out of 600 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingAinos has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageAinos has only been the subject of 1 research reports in the past 90 days.Read more about Ainos' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Ainos is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ainos is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAinos has a P/B Ratio of 3.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.32% of the float of Ainos has been sold short.Short Interest Ratio / Days to CoverAinos has a short interest ratio ("days to cover") of 0.59, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ainos has recently increased by 50.02%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAinos does not currently pay a dividend.Dividend GrowthAinos does not have a long track record of dividend growth. News and Social Media1.4 / 5News Sentiment0.16 News SentimentAinos has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Ainos this week, compared to 2 articles on an average week. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Ainos insiders have sold 2,227.48% more of their company's stock than they have bought. Specifically, they have bought $15,435.00 in company stock and sold $359,247.00 in company stock.Percentage Held by Insiders9.79% of the stock of Ainos is held by insiders.Percentage Held by InstitutionsAinos has minimal institutional ownership at this time.Read more about Ainos' insider trading history. Receive AIMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AIMD Stock News HeadlinesAinos, Inc.: Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental ManagementAugust 19 at 1:54 PM | finanznachrichten.deAinos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical IntelligenceAugust 17 at 9:27 AM | finance.yahoo.comAnthropic Just Became the First Trillion-Dollar Private CompanyAnthropic is now worth more than a trillion dollars, making it the first private company to reach that milestone. Its valuation exceeds every American airline combined and even tops the U.S. defense budget. The company's annualized revenue grew 80 times over in the first quarter alone. Anthropic has already filed IPO paperwork, with some estimates pointing to a public debut as early as October.August 20 at 1:00 AM | Weiss Ratings (Ad)Ainos, Inc.: Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment AdvancesAugust 13, 2026 | finanznachrichten.deAIMD: Ainos is Building an AI Platform Around Digital ScentAugust 5, 2026 | msn.comInterview with Jack Lu, Head of Corporate Development of Ainos, Inc.June 29, 2026 | msn.comAinos, Inc.: Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research ProgramJune 17, 2026 | finanznachrichten.deAinos Sinks on Release of New ArticleJune 3, 2026 | baystreet.caSee More Headlines AIMD Stock Analysis - Frequently Asked Questions How have AIMD shares performed this year? Ainos' stock was trading at $1.64 at the beginning of 2026. Since then, AIMD stock has decreased by 11.6% and is now trading at $1.45. How were Ainos' earnings last quarter? Ainos, Inc. (NASDAQ:AIMD) issued its quarterly earnings data on Monday, August, 3rd. The company reported ($0.62) earnings per share for the quarter. The company had revenue of $0.15 million for the quarter. Ainos had a negative net margin of 11,912.10% and a negative trailing twelve-month return on equity of 217.50%. When did Ainos' stock split? Ainos shares reverse split on Thursday, December 14th 2023.The 1-5 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. When did Ainos IPO? Ainos (AIMD) raised $3 million in an initial public offering (IPO) on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager. How do I buy shares of Ainos? Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ainos own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ainos investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE). Company Calendar Last Earnings8/03/2026Today8/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 AIMD's financial health is in the Yellow zone, according to TradeSmith. AIMD has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry Technology Hardware, Storage & Peripherals Sub-IndustryTechnology Hardware, Storage & Peripherals Current SymbolNASDAQ:AIMD Previous SymbolNASDAQ:AIMD CIK1014763 Webwww.ainos.com Phone858-869-2986Fax806-376-9301Employees40Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.77 million Net Margins-11,912.10% Pretax Margin-8,760.00% Return on Equity-217.50% Return on Assets-67.87% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.12 Sales & Book Value Annual Sales$120 thousand Price / Sales89.18 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book3.30Miscellaneous Outstanding Shares7,380,000Free Float6,661,000Market Cap$10.70 million OptionableNot Optionable Beta2.46 10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NASDAQ:AIMD) was last updated on 8/20/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredAnthropic Just Became the First Trillion-Dollar Private CompanyAnthropic is now worth more than a trillion dollars, making it the first private company to reach that milesto...Weiss Ratings | SponsoredLook at this $5 stock’s addressA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...Freedom Financial | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredOne Ticker Tied to a Major White House Move You Should KnowLarry Benedict made 274 million dollars for his clients by spotting major market moves before they happened. ...Brownstone Research | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
